605 related articles for article (PubMed ID: 16315241)
21. F18-FDG-PET evaluation of patients for resection of colorectal liver metastases.
Huguet EL; Old S; Praseedom RK; Balan KK; Gibbs P; Jamieson NV
Hepatogastroenterology; 2007 Sep; 54(78):1667-71. PubMed ID: 18019690
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
[TBL] [Abstract][Full Text] [Related]
23. Role of FDG-PET in surgical management of patients with colorectal liver metastases.
Teague BD; Morrison CP; Court FG; Chin VT; Costello SP; Kirkwood ID; Maddern GJ
ANZ J Surg; 2004 Aug; 74(8):646-52. PubMed ID: 15315564
[TBL] [Abstract][Full Text] [Related]
24. Impact of 18F-FDG PET/CT on therapeutic decisions in patients with colorectal cancer and liver metastases.
Georgakopoulos A; Pianou N; Kelekis N; Chatziioannou S
Clin Imaging; 2013; 37(3):536-41. PubMed ID: 23116727
[TBL] [Abstract][Full Text] [Related]
25. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.
Lubezky N; Metser U; Geva R; Nakache R; Shmueli E; Klausner JM; Even-Sapir E; Figer A; Ben-Haim M
J Gastrointest Surg; 2007 Apr; 11(4):472-8. PubMed ID: 17436132
[TBL] [Abstract][Full Text] [Related]
26. Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.
Strasberg SM; Dehdashti F
J Surg Oncol; 2010 Dec; 102(8):955-9. PubMed ID: 21165998
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.
Niekel MC; Bipat S; Stoker J
Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538
[TBL] [Abstract][Full Text] [Related]
28. FDG-PET for the pre-operative evaluation of colorectal liver metastases.
Arulampalam TH; Francis DL; Visvikis D; Taylor I; Ell PJ
Eur J Surg Oncol; 2004 Apr; 30(3):286-91. PubMed ID: 15028310
[TBL] [Abstract][Full Text] [Related]
29. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
Abdel-Nabi H; Doerr RJ; Lamonica DM; Cronin VR; Galantowicz PJ; Carbone GM; Spaulding MB
Radiology; 1998 Mar; 206(3):755-60. PubMed ID: 9494497
[TBL] [Abstract][Full Text] [Related]
30. Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.
Ayez N; de Ridder J; Wiering B; Oyen WJ; de Wilt JH; Verhoef C
Dig Surg; 2013; 30(4-6):451-8. PubMed ID: 24458160
[TBL] [Abstract][Full Text] [Related]
31. Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet.
Zealley IA; Skehan SJ; Rawlinson J; Coates G; Nahmias C; Somers S
Radiographics; 2001 Oct; 21 Spec No():S55-69. PubMed ID: 11598248
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET.
Rydzewski B; Dehdashti F; Gordon BA; Teefey SA; Strasberg SM; Siegel BA
AJR Am J Roentgenol; 2002 Feb; 178(2):353-8. PubMed ID: 11804891
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
34. Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases.
Wiering B; Adang EM; van der Sijp JR; Roumen RM; de Jong KP; Comans EF; Pruim J; Dekker HM; Ruers TJ; Krabbe PF; Oyen WJ
Nucl Med Commun; 2010 Nov; 31(11):938-44. PubMed ID: 20856152
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis.
Zhang C; Chen Y; Xue H; Zheng P; Tong J; Liu J; Sun X; Huang G
Int J Cancer; 2009 Jan; 124(1):167-73. PubMed ID: 18844237
[TBL] [Abstract][Full Text] [Related]
36. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
37. The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer.
Rohren EM; Paulson EK; Hagge R; Wong TZ; Killius J; Clavien PA; Nelson RC
Clin Nucl Med; 2002 Aug; 27(8):550-5. PubMed ID: 12169999
[TBL] [Abstract][Full Text] [Related]
38. A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases.
Daza JF; Solis NM; Parpia S; Gallinger S; Moulton CA; Belley-Cote EP; Levine MN; Serrano PE
Eur J Surg Oncol; 2019 Aug; 45(8):1341-1348. PubMed ID: 30928334
[TBL] [Abstract][Full Text] [Related]
39. Staging recurrent metastatic colorectal carcinoma with PET.
Delbeke D; Vitola JV; Sandler MP; Arildsen RC; Powers TA; Wright JK; Chapman WC; Pinson CW
J Nucl Med; 1997 Aug; 38(8):1196-201. PubMed ID: 9255148
[TBL] [Abstract][Full Text] [Related]
40. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
